|
J Biol Chem, Vol. 273, Issue 40, 25654-25658, October 2, 1998
Regulation of DNA-dependent Protein Kinase by the Lyn
Tyrosine Kinase*
Shailendra
Kumar ,
Pramod
Pandey ,
Ajit
Bharti ,
Shengfang
Jin§,
Ralph
Weichselbaum¶,
David
Weaver§,
Donald
Kufe , and
Surender
Kharbanda
From the Department of Adult Oncology, Dana-Farber
Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, the ¶ Department of Radiation and Cellular Biology, University of
Chicago, Chicago, Illinois 60637, and the § Department of
Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts 02115
 |
ABSTRACT |
The Src-like protein-tyrosine kinase Lyn is
activated by ionizing radiation and certain other DNA-damaging agents,
whereas the DNA-dependent protein kinase (DNA-PK),
consisting of the catalytic subunits (DNA-PKcs) and
Ku DNA-binding components, requires DNA double-stranded breaks for
activation. Here we demonstrate that Lyn associates constitutively with
DNA-PKcs. The SH3 domain of Lyn interacts directly with
DNA-PKcs near a leucine zipper homology domain. We also
show that Lyn phosphorylates DNA-PKcs but not Ku in
vitro. The interaction between Lyn and DNA-PKcs inhibits DNA-PKcs activity and the ability of DNA-PKcs
to form a complex with Ku/DNA. These results support the hypothesis
that there are functional interactions between Lyn and
DNA-PKcs in the response to DNA damage.
 |
INTRODUCTION |
Mammalian cells respond to DNA damage with cell cycle arrest,
activation of DNA repair, and, in the event of irreparable lesions, the
induction of apoptosis. The signals controlling responses to genotoxic
stress, while of importance to mutagenesis and treatment with certain
anti-cancer agents, remain unclear. Certain insights, however, have
been derived from the finding that DNA-damaging agents activate the
c-Abl protein-tyrosine kinase (PTK)
(1-4).1 c-Abl is detectable
in a nuclear complex with the DNA-dependent protein kinase
(DNA-PK) and is activated in part in the response to ionizing radiation
(IR) by a DNA-PK-dependent mechanism (5). Activation of
c-Abl is associated with binding to the p53 tumor suppressor and the
induction of growth arrest in G1 phase through down-regulation of the cyclin-dependent kinase 2 (Cdk2) (6, 7). Other studies have demonstrated that c-Abl contributes to DNA
damage-induced apoptosis (8, 9). These findings have supported a role
for c-Abl in regulating the growth arrest and apoptotic responses to
genotoxic stress.
c-Abl is present in a nuclear complex that includes the Src-like Lyn
PTK (10). Lyn, like c-Abl, is activated by IR and other DNA damaging
agents (11-14). The activation of nuclear Lyn by DNA damage is
associated with binding of Lyn to Cdc2 (11-14). Lyn phosphorylates Cdc2 on Tyr-15 and thereby inhibits Cdc2 activity (11-14). Whereas activation of Cdc2 in a complex with cyclin B is required for the
transition of cells from G2 to M phase (15), inhibition of
Cdc2 by Lyn could contribute in part to the arrest at G2/M phase following exposure to DNA damaging agents. Alternatively, binding
of Lyn to Cdc2 may prevent the interaction of Cdc2 with proteins such
as c-Src that play a functional role in mitosis (16). Other studies
have indicated that the activation of Lyn is not restricted to cells in
G2. In this context, arrest of cells in G1/S
phase by 1- -D-arabinofuranosylcytosine is associated with activation of Lyn and binding of Lyn to Cdk2 (17). Thus, the
available evidence suggests that the Lyn PTK, like c-Abl, plays a role
in the cell cycle arrest response to DNA damaging agents.
DNA-PK, a complex of three proteins, is involved in the repair of DNA
double-stranded breaks, V(D)J recombination, and transcription (18-22). The 470-kDa catalytic subunit of DNA-PK
(DNA-PKcs) is activated by binding with the 70- and 80-kDa
Ku heterodimer to sites of DNA damage (23-26). Under some conditions,
DNA-PK is a self-contained kinase that is activated by direct
interaction with double-stranded DNA, whereas Ku stabilizes binding of
DNA-PK to DNA ends (21, 27). Among the many substrates of activated DNA-PKcs are p53, c-Abl, and Cdc2 (5, 19, 26).
Autophosphorylation of DNA-PKcs inhibits its activity by
inducing the dissociation of DNA-PKcs from DNA (28).
Phosphorylation of DNA-PKcs by c-Abl also inhibits the
ability of DNA-PK to form a complex with DNA (5). c-Abl, like Ku,
associates with DNA-PKcs near the kinase homology region
(29). c-Abl phosphorylates DNA-PKcs in the C-terminal region and thereby dissociates DNA-PKcs from the Ku-DNA
complex (29). Otherwise, little is known about the regulation of DNA-PK activity.
The findings that c-Abl forms a nuclear complex with Lyn (10) and that
c-Abl interacts with DNA-PK prompted studies on a potential interaction
between Lyn and DNA-PK. The present results demonstrate that Lyn binds
directly to DNA-PK. We also show that Lyn phosphorylates
DNA-PKcs and inhibits DNA-PKcs activity.
 |
MATERIALS AND METHODS |
Cell Culture--
U-937 monoblastic leukemia cells (ATCC,
Rockville, MD) were grown in RPMI 1640 media containing 10%
heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine. Irradiation
was performed at room temperature using a Gammacell-1000 (Atomic Energy
of Canada, Ottawa, ON, Canada) under aerobic conditions with
137Cs source emitting at a fixed dose rate of 0.76 gray/min.
Immunoprecipitation and Immunoblot Analysis--
Preparation of
cell lysates and immunoprecipitations were performed as described (3).
Soluble proteins were incubated with anti-Lyn (Upstate Biotechnology
Inc., Lake Placid, NY) or anti-DNA-PK (Upstate Biotechnology Inc.) for
1 h and precipitated with protein A-Sepharose for an additional
1 h. The resulting immune complexes were washed three times with
lysis buffer, separated by electrophoresis in SDS-polyacrylamide gels,
and transferred to nitrocellulose filters. The residual binding sites
were blocked by incubating the filters in 5% dry milk in
phosphate-buffered saline and 0.05% Tween 20 for 1 h at room
temperature followed by a 1-h incubation with anti-DNA-PK or anti-Lyn
antibodies. The antigen-antibody complexes were visualized by enhanced
chemiluminescence (ECL detection system, Amersham Pharmacia Biotech).
Signal intensities were determined by densitometeric analysis
(UltroScan; LKB, Brommer, Sweden).
Production of GST-Lyn Fusion Protein--
The pGEX plasmid
encoding a GST-Lyn (amino acids 1-243) fusion protein (30) was
transfected into Escherichia coli DH5 , and the fusion
protein was prepared by inducing log phase cells with
isopropyl- -D-thiogalactopyranoside. The cell pellets
were lysed by sonication. The fusion proteins were purified by affinity chromatography using glutathione-Sepharose beads (Amersham Pharmacia Biotech) as described (30) and equilibrated in lysis buffer.
Fusion Protein Binding Assays and Immunoblotting--
Total cell
lysates were incubated with 5 µg of immobilized GST or the indicated
GST fusion proteins for 2 h at 4 °C (31). Protein complexes
were washed three times with lysis buffer and boiled for 5 min in SDS
sample buffer. The complexes were separated by electrophoresis in 5%
SDS-polyacrylamide gels and then transferred to nitrocellulose paper.
After blocking in 5% dry milk in phosphate-buffered saline and 0.05%
Tween 20 for 1 h at room temperature, the filters were incubated
for 1 h with anti-DNA-PK antibody and analyzed as described
above.
In Vitro Transcription/Translation of DNA-PK
Fragments--
DNA-PKcs polypeptides were prepared using a
coupled in vitro transcription/translation method (Promega)
with templates generated from the DNA-PKcs cDNA by
polymerase chain reaction as described (29). Lyn binding to in
vitro translated DNA-PKcs polypeptides was assayed by
incubating GST-Lyn SH3 (5 µg) in 20 µl of MB (10 mM
Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 10% glycerol,
1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin,
pepstatin, and aprotinin) with equal amounts of each in
vitro translated [35S]DNA-PKcs product
for 1-2 h at 4 °C. A separate incubation of the
[35S]DNA-PKcs product with GST was used as a
negative control. The beads were washed four times in 1 ml of MB at
4 °C, and proteins were eluted by boiling in 2× SDS sample buffer
(100 mM Tris-HCl, pH 7.0, 4% SDS, 720 nM
2-mercaptoethanol, 5 mg/ml bromphenol blue). Samples were analyzed by
SDS-PAGE and autoradiography.
Direct Interaction of DNA-PKcs with
Lyn--
Purified DNA-PK (Promega) was incubated with purified Lyn
(Upstate Biotechnology Inc.) in lysis buffer for 1 h at 4 °C.
After incubation, proteins were subjected to immunoprecipitation with anti-Lyn or PIRS, and the precipitates were analyzed by immunoblotting with anti-DNA-PK antibody.
In Vitro Phosphorylation of DNA-PK by Lyn--
Purified DNA-PK
(Promega, 0.5 µg) was incubated in the absence of DNA in kinase
buffer containing [ -32P]ATP with purified
kinase-active Lyn (Upstate Biotechnology Inc.) for 20 min at 30 °C.
The reaction was terminated by the addition of SDS-PAGE sample buffer,
and reaction products were analyzed by SDS-PAGE and autoradiography.
In vitro kinase reactions containing active or
heat-inactivated (HI) Lyn and DNA-PKcs were also performed with cold ATP. Proteins were separated by SDS-PAGE, transferred to
nitrocellulose filters, and analyzed by immunoblotting with anti-P-Tyr
(Upstate Biotechnology Inc.). Purified Ku (provided by Dr. Lees-Miller;
0.5 µg) was incubated in kinase buffer containing [ -32P]ATP and purified kinase-active Lyn for 20 min at
30 °C. The reaction was terminated by the addition of SDS-PAGE
sample buffer, and reaction products were analyzed by SDS-PAGE and
autoradiography.
Dissociation of DNA-PK from DNA by Lyn--
DNA-PK/Ku (1 µg,
Promega) was incubated with double-stranded DNA-cellulose beads (15 µg; U. S. Biochemical Corp.) in kinase buffer (25 mM
HEPES, pH 7.4, 75 mM KCl, 10 mM
MgCl2, 1 mM dithiothreitol, 0.2 mM
EGTA, 0.1 mM EDTA) for 30 min at room temperature. The DNA-cellulose beads were then washed and resuspended in kinase buffer.
Kinase reactions containing beads, 100 µM ATP and active Lyn (Upstate Biotechnology Inc.), HI Lyn, or MEK1 (Upstate
Biotechnology Inc.) kinases were incubated for 15 min at 30 °C. To
ensure that phosphorylation was not due to DNA-PK, 20 µM
wortmannin (Sigma) was added to inhibit DNA-PK activity (5). The
supernatant fraction was obtained by sedimentation of the beads.
Following washing of the beads with kinase buffer, the beads and
supernatant fraction were boiled in SDS sample buffer. Proteins were
separated by 5% or 10% SDS-PAGE and analyzed by immunoblotting with
anti-DNA-PK or anti-Ku antibodies. Signal intensities were determined
by densitometric analysis (UltroScan).
Inactivation of DNA-PK by Phosphorylation with Lyn--
Purified
DNA-PK was incubated with purified kinase-active Lyn or HI Lyn in
kinase buffer containing [ 32P]ATP for 15 min at
30 °C. The reactions containing the phosphorylated DNA-PK were then
incubated with GST-p53 and [ 32P]ATP in KB for an
additional 15 min at 30 °C. As controls, purified Lyn was also
incubated with GST-p53 in the presence and absence of DNA. The kinase
reactions were stopped by boiling in 2× SDS sample buffer. Eluted
proteins were analyzed by SDS-PAGE and autoradiography.
 |
RESULTS AND DISCUSSION |
To determine whether nuclear Lyn associates with DNA-PK, we
subjected anti-Lyn immunoprecipitates to immunoblot analysis with anti-DNA-PK antibodies. Whereas immunoprecipitates obtained with PIRS
had no detectable DNA-PKcs, immunoprecipitation with the anti-Lyn antibody revealed the presence of complexes containing DNA-PKcs (Fig.
1A). To evaluate the
stoichiometry of interaction between DNA-PKcs and Lyn, we
subjected U-937 cell lysates to immunoprecipitation with anti-Lyn and
analyzed the precipitates by immunoblotting with anti-DNA-PK. Signal
intensities from before and after anti-Lyn immunoprecipitation were
compared by laser densitometric scanning. The results demonstrate that
approximately 25% of DNA-PKcs is associated with Lyn (data
not shown). Because exposure of cells to IR is associated with
activation of both Lyn (11) and DNA-PK (24), we also investigated
whether IR affects the interaction between these proteins. IR treatment
was associated with a reproducible increase in the association of Lyn
with DNA-PKcs to some extent (Fig. 1B). To
confirm binding of Lyn and DNA-PKcs, cell lysates were
incubated with a GST fusion protein prepared from the 1-243 amino acid
fragment of Lyn that includes a unique N-terminal region, Src homology
3 (SH3) and SH2 domains but not kinase domains (30) (Fig.
1C). Adsorbates obtained with GST-Lyn 1-243 but not with GST demonstrated binding of DNA-PKcs (Fig. 1D
and data not shown). Adsorbates obtained with GST-Lyn 1-131 and
GST-Lyn 27-131 but not with GST-Lyn 131-243 also revealed specific
binding of DNA-PKcs to the Lyn SH3 domain (Fig.
1D). These findings indicate that the SH3 domain of Lyn
contributes to the association with DNA-PK.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Association of DNA-PK and Lyn.
A, lysates from U-937 cells were subjected to
immunoprecipitation with PIRS or anti-Lyn. Immunoprecipitates were
analyzed by immunoblotting with anti-DNA-PK. Cell lysate was also
subjected to immunoprecipitations with anti-DNA-PK as a positive
control. B, U-937 cells were treated with 20-gray IR and
harvested at the indicated times. Lysates were then subjected to
immunoprecipitation with anti-Lyn. Lysate was also used directly as a
positive control. Immunoprecipitates were analyzed by immunoblotting
with anti-DNA-PK. C, schematic diagrams of various Lyn
constructions. D, U-937 cell lysate was incubated with
GST-Lyn 131-243, GST-Lyn 1-243, GST-Lyn 1-131, or GST-Lyn 27-131
fusion proteins. The adsorbates were analyzed by immunoblotting with
anti-DNA-PK. IB, immunoblot.
|
|
To assess whether Lyn binds directly to DNA-PKcs, we
incubated purified DNA-PKcs with Lyn. Anti-Lyn
immunoprecipitates were analyzed by immunoblotting with anti-DNA-PK. In
contrast to PIRS, immunoprecipitation with anti-Lyn revealed the
presence of DNA-PKcs (Fig.
2A). These findings support a
direct interaction between DNA-PKcs and Lyn. To assess
where Lyn binds to DNA-PKcs, we prepared fragments of
DNA-PKcs (Fig. 2B) by in vitro
transcription/translation (29). Equal quantities of the
DNA-PKcs in vitro translation products were
incubated with GST-Lyn 1-243 bound to glutathione-Sepharose beads.
Analysis of the adsorbates by autoradiography demonstrated binding of
Lyn to DNA-PKcs fragments 8, 11, and 14 (data not shown). These results support direct binding of Lyn to a leucine zipper region
in DNA-PKcs (amino acids 1503-1538). Various fragments of
DNA-PKcs were also studied for binding to the Lyn SH3 domain. The Lyn
SH3 domain binds to proline-rich sequences with the consensus XPPXXPX. Consistent with the presence
of such a sequence (REFPPGTPRFNN, amino acids 1744-1755; fragments 11 and 14) in DNA-PKcs, the results of Lyn SH3 binding assays
with in vitro translated DNA-PKcs fragments 11 and 14 confirmed a direct interaction (Fig. 2, C and
D, and data not shown). By contrast, there was no apparent
binding of Lyn SH3 to other DNA-PKcs fragments (Fig.
2B). Collectively, these studies indicate that the
association between Lyn and DNA-PKcs occurs by direct
interaction of the Lyn SH3 domain with DNA-PKcs amino acids
1520-1976.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Direct interaction between Lyn and
DNA-PKcs. A, purified DNA-PK was incubated
with Lyn in lysis buffer for 1 h at 4 °C, and anti-Lyn
immunoprecipitates were analyzed by immunoblotting with anti-DNA-PK.
PIRS was used as a negative control. B, protein fragments
from various regions of the DNA-PKcs. C, GST Lyn
1-131 bound to glutathione-Sepharose was incubated with in
vitro translated fragments of
[35S]DNA-PKcs. Following washing, samples
were separated in 10% SDS-PAGE gels and analyzed by autoradiography.
D, GST-Lyn 1-131 or GST bound to glutathione-Sepharose was
mixed with [35S]DNA-PKcs fragments 11 or 14. Following washing, the bound proteins were analyzed by SDS-PAGE and
autoradiography. Arrows indicate specific
DNA-PKcs polypeptides. IB, immunoblot.
|
|
To determine whether Lyn phosphorylates DNA-PKcs, we
incubated purified DNA-PK with active or HI Lyn. There was no
detectable phosphorylation of DNA-PKcs in the presence of
HI Lyn (data not shown). By contrast, kinase reactions that included
kinase-active Lyn demonstrated phosphorylation of DNA-PKcs
(Fig. 3A). Lyn phosphorylation of DNA-PKcs did not require DNA-bound DNA-PK. Also, As a
positive control, DNA-PK was incubated with DNA beads to show
autophosphorylation of DNA-PKcs (Fig. 3A). To
confirm Lyn-dependent phosphorylation of
DNA-PKcs, we incubated purified DNA-PKcs with
active or HI Lyn in kinase buffer containing cold ATP. The
phosphorylated products were analyzed by immunoblotting with
anti-P-Tyr. The results demonstrate Lyn-dependent tyrosine
phosphorylation of DNA-PKcs (Fig. 3B). DNA-PKcs forms a complex with the 70- and 80-kDa Ku
heterodimer (26, 32), and thus we also incubated Lyn with purified Ku in a kinase reaction. In contrast to DNA-PKcs, there was no
detectable phosphorylation of Ku (Fig. 3C). These findings
indicate that Lyn phosphorylates DNA-PKcs and not Ku.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Lyn phosphorylates DNA-PKcs
in vitro. A, purified Lyn kinase was
incubated with purified DNA-PK/Ku in the presence of
[ 32P]ATP for 15 min at 30 °C. DNA-PK/Ku complexes
were also incubated with DNA in the presence of
[ 32P]ATP for 15 min at 30 °C as a positive control
for DNA-PK phosphorylation. In vitro kinase reactions were
analyzed by SDS-PAGE and autoradiography. B, purified Lyn
kinase was incubated with purified DNA-PK/Ku in the presence of cold
ATP for 15 min at 30 °C. DNA-PK/Ku complexes were also incubated
with DNA in the presence of cold ATP for 15 min at 30 °C as a
control for DNA-PK autophosphorylation. In vitro kinase
reactions were analyzed by SDS-PAGE and immunoblotting with anti-P-Tyr
antibody. C, purified Lyn was incubated with purified Ku in
the presence of [ 32P]ATP for 15 min at 30 °C.
Purified DNA-PK/Ku was incubated with DNA beads as a positive control.
In vitro kinase reactions were analyzed by SDS-PAGE and
autoradiography. Sup., supernatant.
|
|
The activation of DNA-PK by binding of DNA-PKcs to Ku/DNA
is associated with phosphorylation of p53 (19). Therefore to assess the
effect of Lyn on DNA-PK activity, we incubated purified
DNA-PKcs/Ku/DNA complexes with active or inactive Lyn and
assessed DNA-PKcs activity using GST-p53 as a substrate. In
the presence of DNA, DNA-PKcs/Ku phosphorylated GST-p53
(Fig. 4A, lane 1).
By contrast, addition of either active or inactive Lyn to the reaction
inhibited GST-p53 phosphorylation (Fig. 4A, lanes
2 and 3). In the absence of DNA-PK, Lyn had little
effect on phosphorylation of GST-p53 (Fig. 4A, lane
4). These findings indicate that the direct interaction of Lyn
with DNA-PKcs, and not necessarily the Lyn kinase function, contributes to the inactivation of DNA-PKcs. To further
assess the functional significance of the interaction of Lyn and
DNA-PK, the DNA-PK/Ku complex was bound to DNA beads and incubated with active or HI Lyn. The reactions included wortmannin to inhibit DNA-PKcs autophosphorylation and thereby inhibit
autodissociation from DNA (28). Incubation with kinase-active or
kinase-inactive Lyn resulted in release of DNA-PKcs from
the beads into the supernatant (Fig. 4B). By contrast,
addition of the MEK1 serine/threonine kinase had no detectable effect
on release of DNA-PKcs from DNA beads (Fig. 4B).
Whereas Lyn phosphorylates DNA-PKcs, but not Ku, we also
asked whether Lyn affects the interaction between Ku and DNA. In the
presence of Lyn, most of the Ku remained associated with the DNA beads
(Fig. 4C). Similar results were obtained with the MEK1
kinase (Fig. 4C). DNA-PKcs released from Ku/DNA
in the presence of Lyn as compared with release of the
DNA-PKcs/Ku complex from DNA was assessed by immunoblot
analysis of proteins in the supernatant and bound to the beads. The
results demonstrate that approximately 40% of DNA-PKcs is
released from Ku in the presence of Lyn (Fig. 4D). By
contrast, only 2-4% of DNA-PKcs/Ku complexes were
released from the DNA beads in the presence of Lyn (Fig. 4D). These findings demonstrate that interaction of Lyn and
DNA-PKcs results in dissociation of DNA-PKcs
and Ku, and thereby directs inhibition of DNA-PKcs
activity.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Lyn inhibits DNA-PKcs
activity. A, purified DNA-PK/Ku/DNA complexes were
incubated with buffer (lane 1), active Lyn kinase
(lane 2), or inactive Lyn (lane 3) in the
presence of [ 32P]ATP for 15 min at 30 °C. GST-p53
fusion protein was then added, and the reactions were incubated in the
presence of [ 32P]ATP for an additional 15 min at
30 °C. Purified Lyn was incubated with GST-p53 in the absence of
DNA-PK/Ku/DNA complexes (lane 4). The reactions were stopped
by the addition of SDS sample buffer and analyzed by SDS-PAGE and
autoradiography. B, purified DNA-PK/Ku was incubated with
DNA beads. The beads were washed and resuspended in kinase buffer.
Kinase reactions containing beads, 20 µM wortmannin, ATP
were incubated with active or HI Lyn for 15 min at 30 °C. MEK1
kinase was used as a negative control. The supernatant fraction was
obtained by sedimentation of the beads. The beads and supernatant
fractions were boiled in SDS sample buffer. Proteins were separated by
5% SDS-PAGE and analyzed by immunoblotting with anti-DNA-PK.
C, purified DNA-PK/Ku was incubated with DNA beads. The
beads were washed and resuspended in kinase buffer. Kinase reactions
containing beads, 20 µM wortmannin, ATP, and purified Lyn
or MEK1 kinases were incubated for 15 min at 30 °C. The supernatant
fraction was obtained by sedimentation of the beads. The beads and
supernatant fractions were boiled in SDS sample buffer. Proteins were
separated by 10% SDS-PAGE and analyzed by immunoblotting with anti-Ku.
D, the percentage release of DNA-PKcs from
Ku/DNA and DNA-PKcs/Ku complexes from DNA are expressed as
the means ± S.D. of three independent experiments. Black
bars, DNA-PKcs released from Ku/DNA; hatched
bars, DNA-PKcs/Ku complexes released from DNA.
Sup., supernatant.
|
|
DNA-PK is essential in the repair of DNA double-stranded breaks that
form in irradiated cells (20, 33, 34). Autophosphorylation inactivates
DNA-PK by a mechanism in which DNA-PKcs dissociates from Ku
(28). Other studies have shown that c-Abl negatively regulates DNA-PK
in the response to DNA damage (5). The present studies demonstrate that
DNA-PK is also regulated by Lyn. DNA-PK constitutively associates with
Lyn by direct binding of the Lyn SH3 domain to an internal region of
DNA-PKcs that includes a leucine zipper. Lyn also
phosphorylates DNA-PKcs. The in vitro findings indicate that the direct binding of Lyn to DNA-PKcs is
sufficient to inhibit DNA-PKcs activity. Thus, constitutive
binding of Lyn and DNA-PKcs could regulate the
accessibility of certain pools of DNA-PKcs for interaction
with Ku/DNA complexes. Lyn-mediated phosphorylation of
DNA-PKcs represent another level of DNA-PKcs regulation. These results are in concert with the demonstration that
the interaction between DNA-PKcs and Lyn induces the
dissociation of DNA-PKcs from the Ku/DNA complex and
thereby inhibits DNA-PKcs activity. The activation of Lyn
by IR and other DNA damaging agents contributes to the down-regulation
of Cdc2 (13-16), indicating that Lyn is an effector of cell cycle
progression in the response to DNA damage. The present findings support
a function for Lyn in the regulation of DNA repair. Accordingly,
interactions between Lyn and DNA-PKcs may play a role in
releasing DNA-PKcs from Ku/DNA complexes after repair to
permit relocation at new sites of DNA damage.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Stephen Jackson for providing
human DNA-PK fragments, Dr. S. P. Lees-Miller for providing
purified Ku, Dr. Vimla Band for the GST-p53 cDNA construct, Dr.
Hamid Band for anti-Ku antibody (GE 9.2), and Dr. J. Cambier for
GST-Lyn constructs. We also thank Andrew Place, Atsuko Nakazawa, and
Rebecca Farber for excellent technical assistance.
 |
FOOTNOTES |
*
This investigation was supported by Public Health Service
Grants CA75216 (to S. K.) and CA55241 (to D. K.) awarded by
the National Cancer Institute, Department of Health and Human Services.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 617-632-2938;
Fax: 617-632-2934; E-mail: surender_kharbanda{at}dfci.harvard.edu.
The abbreviations used are:
PTK, protein-tyrosine kinase; IR, ionizing radiation; DNA-PK, DNA-dependent protein kinase; DNA-PKcs, catalytic subunit of DNA-PKGST, glutathione S-transferasePAGE, polyacrylamide gel electrophoresisHI, heat-inactivatedPIRS, preimmune rabbit serumSH, Src homology.
 |
REFERENCES |
-
Kharbanda, S.,
Ren, R.,
Pandey, P.,
Shafman, T. D.,
Feller, S. M.,
Weichselbaum, R. R.,
and Kufe, D. W.
(1995)
Nature
376,
785-788[CrossRef][Medline]
[Order article via Infotrieve]
-
Kharbanda, S.,
Pandey, P.,
Ren, R.,
Feller, S.,
Mayer, B.,
Zon, L.,
and Kufe, D.
(1995)
J. Biol. Chem.
270,
30278-30281[Abstract/Free Full Text]
-
Kharbanda, S.,
Bharti, A.,
Pei, D.,
Wang, J.,
Pandey, P.,
Ren, R.,
Weichselbaum, R.,
Walsh, C. T.,
and Kufe, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6898-6901[Abstract/Free Full Text]
-
Liu, Z.-G.,
Baskaran, R.,
Lea-Chou, E. T.,
Wood, L.,
Chen, Y.,
Karin, M.,
and Wang, J. Y. J.
(1996)
Nature
384,
273-276[CrossRef][Medline]
[Order article via Infotrieve]
-
Kharbanda, S.,
Pandey, P.,
Jin, S.,
Inoue, S.,
Bharti, A.,
Yuan, Z.-M.,
Weichselbaum, R.,
Weaver, D.,
and Kufe, D.
(1997)
Nature
386,
732-735[CrossRef][Medline]
[Order article via Infotrieve]
-
Yuan, Z.-M.,
Huang, Y.,
Whang, Y.,
Sawyers, C.,
Weichselbaum, R.,
Kharbanda, S.,
and Kufe, D.
(1996)
Nature
382,
272-274[CrossRef][Medline]
[Order article via Infotrieve]
-
Yuan, Z.-M.,
Huang, Y.,
Fan, M. M.,
Sawyers, C.,
Kharbanda, S.,
and Kufe, D.
(1996)
J. Biol. Chem.
271,
26457-26460[Abstract/Free Full Text]
-
Yuan, Z.-M.,
Huang, Y.,
Ishiko, T.,
Kharbanda, S.,
Weichselbaum, R.,
and Kufe, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1437-1440[Abstract/Free Full Text]
-
Huang, Y.,
Yuan, Z.-M.,
Ishiko, T.,
Nakada, S.,
Utsugisawa, T.,
Kato, T.,
Kharbanda, S.,
and Kufe, D. W.
(1997)
Oncogene
15,
1947-1952[CrossRef][Medline]
[Order article via Infotrieve]
-
Kharbanda, S.,
Yuan, Z.-M.,
Weichselbaum, R.,
and Kufe, D.
(1997)
Biochim. Biophys. Acta
1333,
1-7
-
Kharbanda, S.,
Yuan, Z.-M.,
Rubin, E.,
Weichselbaum, R.,
and Kufe, D.
(1994)
J. Biol. Chem.
269,
20739-20743[Abstract/Free Full Text]
-
Kharbanda, S.,
Yuan, Z.-M.,
Taneja, N.,
Weichselbaum, R.,
and Kufe, D.
(1994)
Oncogene
9,
3005-3011[Medline]
[Order article via Infotrieve]
-
Yuan, Z.-M.,
Kharbanda, S.,
and Kufe, D.
(1995)
Biochemistry
34,
1058-1063[CrossRef][Medline]
[Order article via Infotrieve]
-
Kharbanda, S.,
Saleem, A.,
Yuan, Z.-M.,
Kraeft, S.,
Weichselbaum, R.,
Chen, L. B.,
and Kufe, D.
(1996)
Cancer Res.
56,
3617-3621[Abstract/Free Full Text]
-
Nurse, P.
(1990)
Nature
344,
503-507[CrossRef][Medline]
[Order article via Infotrieve]
-
Shenoy, S.,
Chackalaparampil, I.,
Bagrodia, S.,
Lin, P.-H.,
and Shalloway, D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7237-7241[Abstract/Free Full Text]
-
Yuan, Z.-M.,
Huang, Y.,
Kraeft, S.-K.,
Chen, L. B.,
Kharbanda, S.,
and Kufe, D.
(1996)
Oncogene
13,
939-946[Medline]
[Order article via Infotrieve]
-
Carter, T.,
Vancurova, I.,
Sun, I.,
Lou, W.,
and DeLeon, S.
(1990)
Mol. Cell. Biol.
10,
6460-6471[Abstract/Free Full Text]
-
Lees-Miller, S. P.,
Sakaguchi, K.,
Ullrich, S. J.,
Appella, E.,
and Anderson, C. W.
(1992)
Mol. Cell. Biol.
12,
5041-5049[Abstract/Free Full Text]
-
Hartley, K. O.,
Gell, D.,
Smith, G. C. M.,
Zhang, H.,
Divecha, N.,
Connelly, M. A.,
Admon, A.,
Lees-Miller, S. P.,
Anderson, C. W.,
and Jackson, S. P.
(1995)
Cell
82,
849-856[CrossRef][Medline]
[Order article via Infotrieve]
-
Chu, G.
(1997)
J. Biol. Chem.
272,
24097-24100[Free Full Text]
-
Jackson, S. P.,
MacDonald, J. J.,
Lees-Miller, S.,
and Tjian, R.
(1990)
Cell
63,
155-165[CrossRef][Medline]
[Order article via Infotrieve]
-
Boubnov, N. V.,
and Weaver, D. T.
(1995)
Mol. Cell. Biol.
15,
5700-5706[Abstract]
-
Lees-Miller, S. P.,
Godbout, R.,
Chan, D. W.,
Weinfeld, M.,
Day, R. S. I.,
Barron, G. M.,
and Allalunis-Turner, J.
(1995)
Science
267,
1183-1185[Abstract/Free Full Text]
-
Gottlieb, T. M.,
and Jackson, S. P.
(1993)
Cell
72,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
-
Lees-Miller, S. P.,
Chen, Y.,
and Anderson, C. W.
(1990)
Mol. Cell. Biol.
10,
6472-6481[Abstract/Free Full Text]
-
Hammarsten, O.,
and Chu, G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
525-530[Abstract/Free Full Text]
-
Chan, D. W.,
and Lees-Miller, S. P.
(1996)
J. Biol. Chem.
271,
8936-8941[Abstract/Free Full Text]
-
Jin, S.,
Kharbanda, S.,
Mayer, B.,
Kufe, D.,
and Weaver, D. T.
(1997)
J. Biol. Chem.
272,
24763-24766[Abstract/Free Full Text]
-
Pleiman, C. M.,
Clark, M. R.,
Timson Gauen, L. K.,
Winitz, S.,
Coggeshall, K. M.,
Johnson, G. L.,
Shaw, A. S.,
and Cambier, J. C.
(1993)
Mol. Cell. Biol.
13,
5877-5887[Abstract/Free Full Text]
-
Kharbanda, S.,
Saleem, A.,
Shafman, T.,
Emoto, Y.,
Weichselbaum, R.,
Woodgett, J.,
Avruch, J.,
Kyriakis, J.,
and Kufe, D.
(1995)
J. Biol. Chem.
270,
18871-18874[Abstract/Free Full Text]
-
Anderson, C. W.,
and Lees-Miller, S. P.
(1992)
Crit. Rev. Eukaryotic Gene Expression
2,
283-314[Medline]
[Order article via Infotrieve]
-
Jackson, S. P.,
and Jeggo, P. A.
(1995)
Trends Biochem. Sci.
20,
412-415[CrossRef][Medline]
[Order article via Infotrieve]
-
Weaver, D. T.
(1995)
Trends Genet.
11,
388-392[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Jeyakumar, X.-f. Liu, H. Erdjument-Bromage, P. Tempst, and M. K. Bagchi
Phosphorylation of Thyroid Hormone Receptor-associated Nuclear Receptor Corepressor Holocomplex by the DNA-dependent Protein Kinase Enhances Its Histone Deacetylase Activity
J. Biol. Chem.,
March 30, 2007;
282(13):
9312 - 9322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Friedmann, M. Caplin, B. Savic, T. Shah, C. J. Lord, A. Ashworth, J. A. Hartley, and D. Hochhauser
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment.
Mol. Cancer Ther.,
February 1, 2006;
5(2):
209 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dip and H. Naegeli
More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit
FASEB J,
May 1, 2005;
19(7):
704 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lucero, D. Gae, and G. E. Taccioli
Novel Localization of the DNA-PK Complex in Lipid Rafts: A PUTATIVE ROLE IN THE SIGNAL TRANSDUCTION PATHWAY OF THE IONIZING RADIATION RESPONSE
J. Biol. Chem.,
June 6, 2003;
278(24):
22136 - 22143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshida, Y. Miki, and D. Kufe
Activation of SAPK/JNK Signaling by Protein Kinase Cdelta in Response to DNA Damage
J. Biol. Chem.,
December 6, 2002;
277(50):
48372 - 48378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshida, R. Weichselbaum, S. Kharbanda, and D. Kufe
Role for Lyn Tyrosine Kinase as a Regulator of Stress-Activated Protein Kinase Activity in Response to DNA Damage
Mol. Cell. Biol.,
August 1, 2000;
20(15):
5370 - 5380.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Yoshida, S. Kharbanda, and D. Kufe
Functional Interaction between SHPTP1 and the Lyn Tyrosine Kinase in the Apoptotic Response to DNA Damage
J. Biol. Chem.,
December 3, 1999;
274(49):
34663 - 34668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kumar, S. Avraham, A. Bharti, J. Goyal, P. Pandey, and S. Kharbanda
Negative Regulation of PYK2/Related Adhesion Focal Tyrosine Kinase Signal Transduction by Hematopoietic Tyrosine Phosphatase SHPTP1
J. Biol. Chem.,
October 22, 1999;
274(43):
30657 - 30663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shen, M. P. Schultz, and K. D. Tew
Glutathione Conjugate Interactions with DNA-Dependent Protein Kinase
J. Pharmacol. Exp. Ther.,
September 1, 1999;
290(3):
1101 - 1106.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. C.M. Smith and S. P. Jackson
The DNA-dependent protein kinase
Genes & Dev.,
April 15, 1999;
13(8):
916 - 934.
[Full Text]
|
 |
|
|